新风险因子加权临床似然模型用于疑似慢性冠脉综合征患者阻塞性冠心病初始验前概率评估的辩论
2024年ESC指南推荐对疑似慢性冠脉综合征患者使用结构化的阻塞性冠心病概率评估,风险因子加权临床似然(RF-CL)模型作为病史采集后的初始步骤,结合年龄、性别、症状特征及五项临床风险因素(如有冠脉钙化数据则纳入)。该模型经校准后较既往模型准确性提高,可帮助分诊并识别极低概率患者以避免不必要检查,但症状特异性、风险因素定义与权重等实践问题仍存争议,本文呈现正反双方观点。
要点
- RF-CL模型推荐用于疑似慢性冠脉综合征患者病史采集后的初始阻塞性冠心病概率评估。
- 模型量化至45%后转为半定量/定性,评分>85%时推荐有创冠脉造影。
- 模型设计用于评估阻塞性冠心病可能性而非缺血,极低概率者可考虑推迟进一步检查。
核心结论
- RF-CL模型无疑改善了阻塞性冠心病的预测,可安全地对大量有症状患者进行降风险分层并减少不必要的检查。
- 在概率评估工具的开发和应用中,需在简单性与实用性之间取得良好平衡,而非以增加复杂性为代价换取更高敏感性。
研究设计与样本
- 本文为辩论形式,呈现关于RF-CL模型实用性的正反双方观点。
- RF-CL模型已在当代人群(包括欧洲、北美和亚洲队列)中进行了广泛外部验证。
主要发现
- RF-CL模型结合年龄、性别、症状特征和五项临床风险因素,如有冠脉钙化数据则纳入。
- 该模型经校准后较既往模型提供更高的准确性。
- 模型可识别阻塞性冠心病极低概率个体,对此类患者应考虑推迟进一步诊断检查。
- RF-CL模型在45%以内为定量评估,之后转为半定量/定性。
- 对于评估评分>85%的极高概率患者,推荐有创冠状动脉造影。
关键数值与推荐
- 2024年ESC指南推荐对疑似慢性冠脉综合征个体使用结构化的阻塞性冠心病概率评估。
- RF-CL模型被推荐为病史采集后的初始步骤。
- 评分>85%时推荐有创冠状动脉造影。
- 模型量化至45%,之后转为半定量/定性。
临床怎么用
- 对疑似慢性冠脉综合征患者,在病史采集后使用RF-CL模型进行初始阻塞性冠心病概率评估以指导分诊。
- 对RF-CL评估为极低概率的阻塞性冠心病患者,可考虑推迟进一步诊断检查。
- 对RF-CL评分>85%的极高概率患者,推荐有创冠状动脉造影。
- 需注意RF-CL模型评估的是阻塞性冠心病可能性而非缺血。
局限性
- 患者症状的特异性和清晰度存在挑战。
- 风险因素的定义和权重尚存问题。
- 其他可增强似然性的富集因素有待明确。
- 评分>85%如何达到尚不完全清楚。
- 模型在45%以上转为半定量/定性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For individuals with suspected chronic coronary syndrome, the 2024 ESC guidelines recommend use of a structured estimate of the probability of obstructive coronary artery disease (CAD). This 'risk factor-weighted clinical likelihood' (RF-CL) model is recommended as the initial step after history taking and combines age, sex, symptom characteristics, and five clinical risk factors, with coronary calcification data, if available. The resulting numerical estimate indicates an initial 'pre-test probability' of obstructive CAD, that has been calibrated to provide improved accuracy compared with previous models. It can help triage patients for appropriate testing and identify individuals with a very low likelihood of obstructive CAD, for whom deferral of further diagnostic tests should be considered. Designed to assess the likelihood of obstructive CAD, the RF-CL model is not designed to predict ischaemia, which may occur in the absence of obstructive coronary disease and could account for patient symptoms. The score is easy and quick to use, with extensive external validation in contemporary populations including European, North American, and Asian cohorts. However, some have questioned the practical application of the RF-CL tool, citing challenges with the specificity and clarity of patient symptoms, definition and weighting of risk factors, as well as the other 'enrichment factors' that can enhance the likelihood. The RF-CL model is quantitative up to 45% and then becomes semi-quantitative/qualitative. For patients considered very high likelihood, with an estimated score > 85%, invasive coronary angiography is recommended, although how this score may be reached is not entirely clear. The RF-CL model undoubtedly improves the prediction of obstructive CAD and can 'de-risk' a significant number of symptomatic patients safely, reducing unnecessary testing. In the development and application of such a probability estimate, there is a need to strike a good balance between simplicity and usefulness, vs increased sensitivity at the expense of greater complexity. Here, the two sides of this Great Debate are presented, to help the reader better evaluate the practical usefulness of the new RF-CL assessment in predicting the probability of obstructive CAD.
引用
- Andreotti F, Thiele H, Vrints C, et al. Great debate: the new risk factor-weighted clinical likelihood model is useful to estimate the initial pre-test probability of obstructive coronary artery disease in individuals with suspected chronic coronary syndromes. Eur Heart J. 2026. PMID: 41823519. doi:10.1093/eurheartj/ehag091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。